BRIDGENE BIOSCIENCES, INC.
Biotech · Private
Small-molecule covalent FLT3 inhibitor (BGS2456) for acute myeloid leukemia
- Grants
- $467K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 22
- 3 granted · 19 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Novel Chemical Proteomics Platform to Expand Druggable Space | $168,331 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia | $298,928 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2246 | CELLF-BIO LLC | — | — |
| 2247 | NOUR HEART, INC. | — | — |
| 2248 | NAPROGENIX, INC. | — | — |
| 2249 | BRIDGENE BIOSCIENCES, INC. | — | — |
| 2250 | OpalGenix, Inc. | — | — |
| 2251 | ProDa BioTech L.L.C. | — | — |
| 2252 | AUMENTA BIOSCIENCES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Inhibitors Of Yap/taz-tead Oncoproteins, Synthesis And Use Thereofgranted
- Method For Proteome-wide Discovery Of Covalent Ligands And Compositions Thereofapplication
- Fgfr Inhibitors For The Treatment Of Cancergranted
- Inhibitors Of Ras Oncoproteinsapplication
- Method For Proteome-wide Discovery Of Covalent Ligands And Compositions Thereofgranted
- Imidazopyridine Inhibitors Of Tyrosine Kinaseapplication
- Inhibitors Of Tyrosine Kinaseapplication
- Inhibitors Of Ras Oncoproteinsapplication
- Inhibitors Of Yap/taz-tead Oncoproteins, Synthesis And Use Thereofapplication
- Method For Proteome-wide Discovery Of Covalent Ligands And Compositions Thereofapplication
- Inhibitors Of Yap/taz-tead Oncoproteins, Synthesis And Use Thereofapplication
- Fgfr Inhibitors For The Treatment Of Cancerapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.